Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2012 Financial Results
Date:11/6/2012

SAN DIEGO, Nov. 6, 2012 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today provided a corporate update and reported financial results for the third quarter ended September 30, 2012.

Arena is preparing for the launch of BELVIQ® (lorcaserin HCl) in the United States, pursuing regulatory approval and collaborations for BELVIQ in additional territories, and selectively advancing its earlier-stage drug candidates. Arena's expected upcoming milestones include the following:

  • Eisai Inc. beginning to market BELVIQ in the United States in early 2013, subject to the US Drug Enforcement Administration's final scheduling designation;
  • Regulatory authorities for the European Union and Switzerland providing their decisions on the Marketing Authorization Applications (MAA) for BELVIQ in the first half of 2013; and
  • Results from the Phase 1 multiple-dose clinical trial of APD811, its internally discovered oral drug candidate for the treatment of pulmonary arterial hypertension (PAH), in the first quarter of 2013.
  • "We are well positioned to deliver significant value to our stockholders by executing on the potential of BELVIQ and strategically advancing our pipeline of internally discovered drug candidates," said Jack Lief, Arena's President and Chief Executive Officer. "We look forward to providing a novel treatment option to patients who need help with chronic weight management. As we prepare for the US launch of BELVIQ, we continue to pursue additional regulatory approvals and collaborations in strategic markets worldwide."

    Recent Developments

  • Established a marketing and supply agreement between its wholly owned subsidiary, Arena Pharmaceuticals GmbH, and Ildong Pharmaceutical Co., Ltd., for BELVIQ. Under the agreement, Arena granted Ildong exclusive rights to market and distribute BELVIQ in South Korea for we
    '/>"/>

  • SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Tuesday, November 6
    2. Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
    3. Arena Pharmaceuticals to Present at Upcoming Investor Conferences
    4. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
    5. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
    6. Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
    7. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
    8. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
    9. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
    10. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
    11. Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2014)... , Sept. 2, 2014 Redspin, Inc., ... penetration testing services, today released an IT security advisory ... "Today,s healthcare CEOs are presiding over the most ... Daniel W. Berger , Redspin,s President and CEO. ... and their Boards of Directors understand why they need ...
    (Date:9/2/2014)... ATLANTA , Sept. 2, 2014  For over a ... show no link between vaccines and autism. But at least ... In a statement , William Thompson ... significant information" linking the MMR vaccine to an increased risk ... of the same data suggests that African American males ...
    (Date:9/2/2014)... Calif. , Sept. 2, 2014 /PRNewswire-iReach/ -- ... just recognized as one of the fastest growing ... past few years, the company has undergone significant ... research, late phase global clinical development, anti-viral and ... 2 years, WCCT Global has successfully participated in ...
    Breaking Medicine Technology:CDC vaccine scientist admits wrongdoing. 2CDC vaccine scientist admits wrongdoing. 3Contract Research Organization WCCT Global Celebrates Being Named as One of the Fastest Growing Companies in America 2
    ... SweetSpot Diabetes Care, Inc. has registered their ... Device Data System (MDDS) with the FDA the Company announced ... Sessions meeting in San Diego, CA. With the ... of data from patient diabetes devices to research tools and ...
    ... Golden Meditech Holdings Limited ("Golden Meditech" or the "Group," ... that the Group has accumulated 754,791 ordinary shares in its ... the open market between December 2010 and March 2011. As ... the issued share capital of CCBC. CCBC is ...
    Cached Medicine Technology:Golden Meditech to Increase Stake in NYSE-listed Affiliate -- China Cord Blood Corporation to 39.5% 2
    (Date:9/2/2014)... At the world-famous Magic Castle in Hollywood, California, famed ... being the first and only female staff Medium. Throughout the ... female magician to hold such a position. , “I’m deeply ... says Misty Lee. “Even since I was a child, magic ... can fascinate guests in much the same way.” , At ...
    (Date:9/2/2014)... (PRWEB) September 02, 2014 QueenBeeTickets.com , ... events, is now stocking James Taylor concert tickets for the ... select U.S. cities from November 1 to the 19th. , ... and again on the 4th of the month. General onsales ... fans are all set to obtain seats for one of ...
    (Date:9/2/2014)... the U.S. has led to public debate about whether ... In January, President Obama also publically stated he is ... Despite the recent shift in views toward marijuana, the ... not well understood. , Now a new ... US High School Seniors: A Comparison of Alcohol and ...
    (Date:9/2/2014)... Smile Squared, a well-known Buy One, Give One ... US-made toothbrush. For every toothbrush purchased, Smile Squared gives ... was created by my wife and me after volunteering ... President of Smile Squared. “There, we saw children who ... of the same children didn't own a toothbrush. We ...
    (Date:9/2/2014)... Tuesday 2 September 2014: The fact that mechanical ... been confirmed by data from the ROPAC registry presented ... Hot Line session by Professor Jolien W. Roos-Hesselink, co-chair ... The registry found that 1.4% of pregnant women with ... baby during pregnancy. , The Registry Of Pregnancy And ...
    Breaking Medicine News(10 mins):Health News:Magician Misty Lee is the First and Only Female Staff Medium at Hollywood’s Magic Castle 2Health News:James Taylor Presale Tickets for 10 November Concerts On Sale Today From Trusted Provider QueenBeeTickets.com 2Health News:NYU study compares consequences of teen alcohol and marijuana use 2Health News:NYU study compares consequences of teen alcohol and marijuana use 3Health News:Smile Squared's Colorful Buy One, Give One Toothbrush Now Available in Schnucks Stores 2Health News:Mechanical heart valves increase pregnancy risk 2Health News:Mechanical heart valves increase pregnancy risk 3
    ... that treats Type-2 diabetes has been shown to prevent ... the growth of breast cancer cells, according to a ... The research, led by pediatrics professor James Trosko ... biological evidence for previously reported epidemiological surveys that long-term ...
    ... European Science Foundation (ESF) has awarded this year,s European ... Max Planck Institute for Demographic Research in Rostock, Germany. ... Vaupel was awarded the prize for his contributions to ... on demographic research. The Prize was awarded on the ...
    ... How will the terrorist attacks in Norway on 22 July ... social scientists at the University of Stavanger (UiS). "Norwegians ... Einar Olsen. "These incidents were so extensive and gruesome that ... He is very interested to see what content Norway will ...
    ... for cancer and epilepsy could also prevent heart attacks, according ... Gothenburg, Sweden, who have been using it to stimulate the ... are normally caused by the formation of a blood clot ... with oxygen and nutrients. The clot reduces the supply of ...
    ... News) -- Some patients with inflammatory bowel disease may ... their use of immunosuppressant drugs to treat the intestinal ... The studies, published in the November issue of ... commonly used to treat patients with irritable bowel disease, ...
    ... By Steven Reinberg HealthDay Reporter , TUESDAY, ... "energy" drinks skyrockets, so do related health problems, a ... almost 10 times more cases of reactions to beverages such ... to a new U.S. government report released Tuesday. More ...
    Cached Medicine News:Health News:Diabetes drug shows promise in reducing risk of cancer 2Health News:ESF awards 13th European Latsis Prize to James Vaupel on pioneering demographic research 2Health News:Coming to terms with terror 2Health News:Coming to terms with terror 3Health News:Coming to terms with terror 4Health News:Substance in cancer medicine could prevent heart attacks 2Health News:Chronic Bowel Disease Drugs Linked to Skin Cancer Risk 2Health News:ER Visits for Energy-Drink Ills Soar in U.S. 2Health News:ER Visits for Energy-Drink Ills Soar in U.S. 3
    ... Atlantech's new tibial guide is designed for ... to choose between "point" or "elbow" aimers ... for creation of the tibial tunnel. The ... design features and the reproducibility and accuracy ...
    The Pinn-ACL Guide can be used to create tibial tunnels of known lengths with a variable angle adjustment of 35 to 60 degrees with the use of a,graduated pin-sleeve....
    Hand surgery basic instrument set...
    Hand surgery basic instrument set with round handled instruments...
    Medicine Products: